DANIEL B. CARR, M.D.
Osteopathic Medicine at Washington St, Boston, MA
License number
Massachusetts 43800
Category
Osteopathic Medicine
Type
Pain Medicine
Address
Address
750 Washington St, Boston, MA 02111
Phone
(617) 636-5000
Personal information
See more information about DANIEL B. CARR at radaris.comName
Address
Phone
527 Pokross St, Fall River, MA 02724
330 Newport Rd, Hull, MA 02045
6 Acrebrook Dr, Granby, MA 01033
428 Marlborough St, Boston, MA 02115
353 Evergreen Rd, Springfield, MA 01119
Organization information
See more information about DANIEL B. CARR at bizstanding.comTufts Medical Center - Daniel B Carr MD
800 Washington St #400, Boston, MA 02111
Categories:
Anesthesiology Physicians, Endocrinology & Metabolism Physicians & Surgeons, Internal Medicine Physicians & Surgeons, ...
Phone:
(617) 636-9710 (Phone)
Payment options:
All Major Cards Accepted
Professional information
Vice Chairman, President &Amp; Chief Medical Officer At Javelin Pharmaceuticals, Inc.
Position:
Vice Chairman, President and Chief Medical Officer at Javelin Pharmaceuticals, Inc.
Location:
Greater Boston Area
Industry:
Pharmaceuticals
Work:
Javelin Pharmaceuticals, Inc.
since 2008
-
Vice Chairman, President and Chief Medical Officer
Javelin Pharmaceuticals, Inc.
2005 - 2008
-
Chief Executive Officer and Chief Medical Officer
IDDS
2004 - 2005
-
Chief Medical Officer
Tufts University School of Medicine
2003 - 2005
-
Director, Master of Science Program in Pain Research, Education, and Policy
Tufts University School of Medicine
1994 - 2005
-
Professor of Anesthesiology and Medicine
Education:
Columbia University College of Physicians and Surgeons 1976
Columbia University in the City of New York 1970
Columbia College 1968
Columbia University in the City of New York 1970
Columbia College 1968
Interests:
Major Research Interests:
1. Clinical trials and outcomes research on pain therapies.
2. Systematic reviews and guidelines for pain therapies.
3. Analgesic peptides and nociception.
Honor & Awards:
• 2007 - June L. Dahl Lectureship Award, American Alliance of Cancer Pain Initiatives
• 2004 - Bonica Lecturer, Annual Meeting, American Society of Regional Anesthesia and Pain Medicine
• 2004 - Bonica Award, Eastern Pain Association
• 2004 - Distinguished Service Award, American Pain Society
• 2003 - The Philipp M. Lippe, MD Award, American Academy of Pain Medicine
• 2000 - Honorary Fellow of the Faculty of Pain Medicine, Australian and New Zealand College of Anaesthetists (FFPMANZCA)
• 1993 - Bernard Schoenberg Memorial Award, American Institute of Life-Threatening Illness and Loss, New York
• 1992 - Citation, U.S. Department of Health and Human Services (for co-chairing Cancer Pain Guideline Panel)
• 1991 - Citation, U.S. Department of Health and Human Services (for co-chairing Acute Pain Guideline Panel)
Dr. Daniel B Carr, Boston MA - MD (Doctor of Medicine)
Specialties:
Endocrinology, Diabetes & Metabolism, Endocrinology & Metabolism
Address:
NEW ENGLAND MEDICAL CTR
750 Washington St SUITE 298, Boston 02111
(617) 636-6044 (Phone), (617) 636-8384 (Fax)
750 Washington St SUITE 298, Boston 02111
(617) 636-6044 (Phone), (617) 636-8384 (Fax)
Certifications:
Anesthesiology, 1989, Diabetes, Metabolism & Endocrinology, 1981, Internal Medicine, 1979, Pain Medicine, 2004
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
NEW ENGLAND MEDICAL CTR
750 Washington St SUITE 298, Boston 02111
Tufts Medical Center
800 Washington Street Pl, Boston 02111
750 Washington St SUITE 298, Boston 02111
Tufts Medical Center
800 Washington Street Pl, Boston 02111
Education:
Medical School
Columbia University / College of Physicians And Surgeons
Graduated: 1976
New York Presbyterian Hospital-Columbia Presbyterian Center
Massachusetts General Hospital
Columbia University / College of Physicians And Surgeons
Graduated: 1976
New York Presbyterian Hospital-Columbia Presbyterian Center
Massachusetts General Hospital
Daniel B Carr, Boston MA
Specialties:
Anesthesiologist
Address:
750 Washington St, Boston, MA 02111
800 Washington St, Boston, MA 02111
800 Washington St, Boston, MA 02111
Education:
Columbia University, College of Physicians and Surgeons - Doctor of Medicine
Massachusetts General Hospital - Fellowship - Endocrinology
Massachusetts General Hospital - Residency - Anesthesiology
Massachusetts General Hospital - Residency - Internal Medicine
New York Presbyterian Hospital-Columbia Presbyterian Center - Residency - Internal Medicine
Massachusetts General Hospital - Fellowship - Endocrinology
Massachusetts General Hospital - Residency - Anesthesiology
Massachusetts General Hospital - Residency - Internal Medicine
New York Presbyterian Hospital-Columbia Presbyterian Center - Residency - Internal Medicine
Board certifications:
American Board of Anesthesiology Certification in Anesthesiology, American Board of Anesthesiology Sub-certificate in Pain Medicine (Anesthesiology), American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Endocrinology and Metabolism (Internal Medicine)
Daniel Barry Carr, Boston MA
Specialties:
Anesthesiology, Pain Medicine, Internal Medicine, Endocrinology and Metabolism, Endocrinology, Diabetes & Metabolism
Work:
Tufts Medical Center
750 Washington St, Boston, MA 02111
750 Washington St, Boston, MA 02111
Education:
Columbia University (1976)
Use Of A Peptide And An Analgesic Pharmaceutical Agent
US Patent:
2010027, Oct 28, 2010
Filed:
Mar 7, 2008
Appl. No.:
12/449944
Inventors:
Andrzej W. Lipkowski - Warszawa, PL
Daniel Carr - Chestnut Hill MA, US
Aleksandra Misicka-Kesik - Piastow, PL
Piotr Kosson - Warszawa, PL
Anna Klinowiecka - Warszawa, PL
Daniel Carr - Chestnut Hill MA, US
Aleksandra Misicka-Kesik - Piastow, PL
Piotr Kosson - Warszawa, PL
Anna Klinowiecka - Warszawa, PL
International Classification:
A61K 38/08, A61P 25/00
US Classification:
514 183
Abstract:
Inflammation caused by disease states such as rheumatism, gout, neurodegeneration and tumours result in the increased effectiveness of the opioid peptide biphalin or its analogues, due likely to the increased permeability of the “blood-brain barrier”, due to which it becomes possible to use the opioid peptide to produce a new analgesic for use during inflammation caused by rheumatism, gout, neurodegeneration, post-surgical or post-accidental trauma or tumours.
Ops Assoc. At Anchor Capital Advisors
Position:
Ops Assoc. at Anchor Capital Advisors
Location:
Greater Boston Area
Industry:
Financial Services
Work:
Anchor Capital Advisors
- Boston Ma since Nov 2011
-
Ops Assoc.
JPM Chase
Apr 2008 - Nov 2011
-
Senior Fund Accountant
Education:
Saint Anselm College
Formulations Of Low Dose Diclofenac And Beta-Cyclodextrin
US Patent:
8580954, Nov 12, 2013
Filed:
Mar 22, 2007
Appl. No.:
11/689931
Inventors:
Curtis Wright - Rockport MA, US
Daniel B. Carr - Chestnut Hill MA, US
Fred H. Mermelstein - Newton MA, US
Daniel B. Carr - Chestnut Hill MA, US
Fred H. Mermelstein - Newton MA, US
Assignee:
Hospira, Inc. - Lake Forest IL
International Classification:
C07H 15/04, C07H 3/06, C08B 37/10, C08B 37/16
US Classification:
53612312
Abstract:
The present invention is directed to a pharmaceutical composition containing a unit dose of a diclofenac compound effective to induce analgesia; and a beta-cyclodextrin compound; wherein the dose of the diclofenac compound is less than 10 mg. The present invention is also directed to methods of treating a subject in need of analgesia with the pharmaceutical compositions of the invention.
Formulations Of Low Dose Diclofenac And Beta-Cyclodextrin
US Patent:
2011021, Sep 8, 2011
Filed:
May 12, 2011
Appl. No.:
13/106697
Inventors:
Curtis Wright - Rockport MA, US
Daniel B. Carr - Chestnut Hill MA, US
Fred H. Mermelstein - Newton MA, US
Daniel B. Carr - Chestnut Hill MA, US
Fred H. Mermelstein - Newton MA, US
International Classification:
A61K 31/196, A61P 29/00
US Classification:
514567
Abstract:
The present invention is directed to a pharmaceutical composition containing a unit dose of a diclofenac compound effective to induce analgesia; and a beta-cyclodextrin compound; wherein the dose of the diclofenac compound is less than 10 mg. The present invention is also directed to methods of treating a subject in need of analgesia with the pharmaceutical compositions of the invention.
Novel Chimeric Analgesic Peptides
US Patent:
2009029, Dec 3, 2009
Filed:
Mar 28, 2007
Appl. No.:
11/692872
Inventors:
Daniel B. Carr - Chestnut Hill MA, US
Andrzej W. Lipkowski - Warsaw, PL
Richard Kream - Roslindale MA, US
Aleksandra Misicka-Kesik - Piastow, PL
Andrzej W. Lipkowski - Warsaw, PL
Richard Kream - Roslindale MA, US
Aleksandra Misicka-Kesik - Piastow, PL
International Classification:
A61K 38/17, A61K 38/02, A61K 38/08, A61K 38/07, A61P 25/00
US Classification:
514 12, 514 2, 514 18, 514 16
Abstract:
The present invention provides a novel chimeric peptide containing an opioid peptide moiety and a nociceptive peptide moiety for producing analgesia.
Novel Antimicrobial Compounds
US Patent:
2003003, Feb 13, 2003
Filed:
Nov 20, 2001
Appl. No.:
09/988792
Inventors:
Andrzej Lipkowski - Warsaw, PL
Daniel Carr - Chestnut Hill MA, US
Daniel Carr - Chestnut Hill MA, US
International Classification:
A61K038/08
US Classification:
514/015000
Abstract:
The invention features an antimicrobial composition comprising a substance P peptide and methods of inhibiting growth of a microorganism by contacting the microorganism with a substance P peptide. Bacterial and fungal pathogens are inhibited by the substance P compositions.